Clinical indications for probiotics: An overview

Clinical Infectious Diseases

Volumn 46, Issue SUPPL. 2, 2008, Pages

  Goldin, Barry R ^a   Gorbach, S L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ACUTE DIARRHEA; ATOPIC DERMATITIS; BIFIDOBACTERIUM; BIOTECHNOLOGY; BLADDER CANCER; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLITIS; COLON CANCER; CONFERENCE PAPER; DENTAL CARIES; DIABETES MELLITUS; DIARRHEA; DRUG EFFICACY; DRUG INDICATION; ENTERITIS; ESCHERICHIA COLI; GRAFT VERSUS HOST REACTION; HELICOBACTER INFECTION; HUMAN; IRRITABLE COLON; LACTIC ACID BACTERIUM; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; LACTOSE INTOLERANCE; MILK ALLERGY; NAUSEA; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RHEUMATOID ARTHRITIS; SACCHAROMYCES BOULARDII; STREPTOCOCCUS SALIVARIUS; TRAVELLER DIARRHEA; URINARY TRACT INFECTION;

ANIMALS; BACTERIA; DENTAL CARIES; GASTROINTESTINAL DISEASES; HUMANS; HYPERSENSITIVITY; PREVENTIVE MEDICINE; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SACCHAROMYCES;

EID: 40049089729     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/523333     Document Type: Conference Paper

References (53)

1. Salminen S, Gibson C, Bouley MC, et al. Gastrointestinal physiology and function: the role of prebiotics and probiotics. Br J Nutr 1998; 80(Suppl 1):S147-71.
2. Savaiano DA, Abou EA, Smith DE, Levitt MD. Lactose malabsorption from yogurt, sweet acidophilus milk, and cultured milk in lactose-deficient individuals. Am J Clin Nutr 1984; 40:1219-23.
3. deVrese M, Stegelmann A, Richter B, Fenseau S, Love C, Schrezenneir J. Probiotics compensation for lactose insufficiency. Am J Clin Nutr 2001; 73:421S-9S.
4. Kim HS, Gilliland SE. Lactobacillus acidophilus as dietary adjunct for milk to aid lactose digestion in humans. J Dairy Sci 1983; 66:959-66.
5. Kolars JC, Levitt MD, Aouj M, Savaino DA. Yogurt - an antidigesting source of lactose. N Engl J Med 1984; 310:1-3.
6. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev 2003; 2:CD003048.
7. Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000; 30:54-60.
8. Shornikova AV, Isolauri E, Burkanova L, Lukovnikova S, Vesikari T. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhea. Acta Paediatr 1997; 86:460-5.
9. Pant AR, Graham SM, Allen SJ, et al. Lactobacillus GG and acute diarrhea in young children in the tropics. J Trop Pediatr 1996; 42:162-5.
10. Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 1995; 14:107-11.
11. Sepp E, Tamm E, Torm S, Lutsar I, Mikelsaar M, Salminen S. Impact of a Lactobacillus probiotic on the faecal microflora in children with shigellosis. Microecol Ther 1995; 23:74-80.
12. Szajewska H, Kotowska M, Murkowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001; 138:361-5.
13. Mastretta E, Longo P, Laccisaglia A, et al. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 2002; 35:527-31.
14. Oberhelman RA, Gilman RH, Sheen P, et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 1999; 134:15-20.
15. Shornikova AV, Cosas I, Mykkanen H, Salo E, Vesikari T. Bactiotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 1997; 16:1103-7.
16. Cetina-Sauri G, Sierra Basto G. Evaluation therapeutique de Saccharomyces boulardii chez des enfants souffrant de diarrhee aigue. Ann Pediatr 1994; 41:397-400.
17. Höchter W, Chase D, Hegenhoff G. Saccharomyces boulardii in treatment of acute adult diarrhoea: efficacy and tolerance of treatment. Münch Med Wochen 1990; 132:188-92.
18. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104:e64.
19. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135:564-8.
20. Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001; 63:1-7.
21. Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97:2744-9.
22. Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15:163-9.
23. Siitonen S, Vapaatalo H, Salminen S, et al. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhea. Ann Med 1990; 22:57-9.
24. Marchand J, Vandenplas Y. Microorganisms administered in the benefit of the host: myths and facts. Eur J Gastroenterol Hepatol 2000; 12:1077-88.
25. Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of travellers' diarrhea by Lactobacillus GG. Ann Med 1990; 22:53-6.
26. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 1997; 4:41-3.
27. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001; 357:1076-9.
28. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109:119-21.
29. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo-controlled trial. Lancet 2003; 361:1869-71.
30. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30:1604-10.
31. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99:179-85.
32. Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 1995; 21:224-6.
33. Gorbach SL, Chang TW, Goldin BR. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; 2:1519.
34. Bennett RG, Gorbach SL, Goldin BR, et al. Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG. Nutr Today 1996; 31(Suppl):35S-8S.
35. Nase L, Hatakka K, Savilahti E, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res 2001; 35:412-20.
36. Bruzzese E, Raia V, Gaudiello G, et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004; 20:813-9.
37. Hatakka K, Savilahti E, Ponka A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centers: double blind, randomized trial. Br Med J 2001; 322:1327.
38. Gluck U, Gebbers JO. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphyloccus aureus, Streptococcus pneumoniae, and β-hemolytic streptococci). Am J Clin Nutr 2003; 77:517-20.
39. Mattila-Sandholm T, Blum S, Collins JK, et al. Probiotics: towards demonstrating efficacy. Trends Food Sci Technol 1999; 10:393-9.
40. Malchow HA. Crohn's disease and Escherichia coli: a new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol 1997; 25:653-8.
41. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 2000; 45:1462-4.
42. Venturi A, Gionchetti P, Rizzello F, et al. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 1999; 13:1103-8.
43. Brigdi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or funcational diarrhea. Res Microbiol 2001; 152:735-41.
44. Baharav E, Mor F, Halpern M, Weinberger A. Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J Nutr 2004; 134:1964-9.
45. Hatakka K, Martio J, Korpela M, et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis - a pilot study. Scand J Rheumatol 2003; 32:211-5.
46. Goldin BR, Gualtieri LJ, Moore RP. The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rate. Nutr Cancer 1996; 25:197-204.
47. Lim BK, Mahendran R, Lee YK, Bay BH. Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse. Jpn J Cancer Res 2002; 93:36-41.
48. 1 to cell wall components of Lactobacillus rhamnosus strain GG. Food Addit Contam 2004; 21:158-64.
49. Haskard C, Binnion C, Ahokas J. Factors affecting the sequestration of aflatoxin by Lactobacillus rhamnosus strain GG. Chem Biol Interact 2000; 128:39-49.
50. Nanji AA, Khettry U, Sadrzadeh SM. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med 1994; 205:243-7.
51. Tabuchi M, Ozaki M, Tamura A, et al. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 2003; 67:1421-4.
52. Gerbitz A, Schultz M, Wilke A, et al. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood 2004; 103:4365-7.
53. Doron S, Snydman DR, Gorbach SL. Lactobacillus GG: bacteriology and clinical applications. Gastroenterol Clin North Am 2005; 34:483-98.